...
【24h】

A Novel Test for the Measurement of Skin Cholesterol

机译:一种新的皮肤胆固醇测定测试

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Increased serum cholesterol is a risk factor for atherosclerosis and coronary artery disease (CAD) (1)(2). Reduction of serum cholesterol has, therefore, been targeted for the prevention and management of CAD with cholesterol screening and is the primary tool for initial risk assessment (3)(4). Cholesterol, however, can also be quantified in skin.Skin reflects the vascular changes associated with age and aortic atherosclerosis. A simple, noninvasive procedure for the estimation of skin cholesterol, the “three-drop” test, has been proposed as an alternative screening method (5). The test, which uses three different concentrations of a digitonin–copolymer–horseradish peroxidase (HRP) conjugate and visual scoring, is capable of discriminating among healthy individuals, those at risk of developing atherosclerosis, and those with overt disease. Cholesterol 1,2,3TM is a refinement of this procedure. We describe here some properties of this test and report on our initial evaluation in a prospective clinical trial.Cholesterol 1,2,3 uses quantitative interpretation and a single concentration of detector. Briefly, the detector and the positive control each are added to die-cut wells in a foam template affixed to the palm. After a 1-min incubation, the reagents are removed by blotting and the HRP substrate is added to these wells and to a third well, which serves as negative control. After an additional 2-min incubation, color development in the center test well is measured by reflectance with a hand-held instrument (MD22 Spectrophotometer; X-Rite, Inc.) interfaced with a computer, and the result is reported numerically as the hue. Assay validity is assessed by visual interpretation of control wells.The specificities of digitonin conjugates have been demonstrated previously with several model systems [crystalline cholesterol, cholesterol-rich tissue sections, and antibody-immobilized LDL-cholesterol (LDL-C)], and the amount of skin-bound conjugate has been shown to correlate with epidermal cholesterol content (5). We extended the specificity …
机译:血清胆固醇升高是动脉粥样硬化和冠状动脉疾病(CAD)的危险因素(1)(2)。因此,降低胆固醇水平已成为通过胆固醇筛查预防和管理CAD的目标,并且是进行初始风险评估的主要工具(3)(4)。然而,胆固醇也可以在皮肤中定量。皮肤反映出与年龄和主动脉粥样硬化相关的血管变化。已经提出了一种简单的,非侵入性的皮肤胆固醇评估程序,即“三滴”测试,作为替代的筛选方法(5)。该测试使用三种不同浓度的洋地黄皂苷-共聚物-辣根过氧化物酶(HRP)结合物和视觉评分,能够区分健康个体,有发展成动脉粥样硬化风险的人和患有明显疾病的人。胆固醇1,2,3TM是该程序的改进。我们在此描述该测试的一些特性,并在一项前瞻性临床试验中报告我们的初步评估。胆固醇1,2,3使用定量解释和单一浓度的检测器。简而言之,将检测器和阳性对照分别添加到固定在手掌上的泡沫模板的冲切孔中。温育1分钟后,通过印迹去除试剂,并将HRP底物添加到这些孔和用作阴性对照的第三个孔中。再孵育2分钟后,使用与计算机连接的手持式仪器(MD22分光光度计; X-Rite,Inc.)通过反射率测量中心测试孔中的显色,结果以色相数字形式报告。 。通过对对照孔的目视解释来评估测定的有效性。以前已经通过几种模型系统[结晶胆固醇,富含胆固醇的组织切片和固定有抗体的LDL-胆固醇(LDL-C)]证明了洋地黄皂苷结合物的特异性。皮肤结合缀合物的量已显示与表皮胆固醇含量相关(5)。我们扩展了特异性……

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号